So doctor, what exactly is wrong with my muscles? Glutaric aciduria type II presenting in a teenager.

PubWeight™: 1.09‹?› | Rank: Top 10%

🔗 View Article (PMID 16527485)

Published in Neuromuscul Disord on March 09, 2006

Authors

Michael W Beresford1, Morteza Pourfarzam, Doug M Turnbull, Joyce E Davidson

Author Affiliations

1: Department of Rheumatology, Royal Liverpool Children's NHS Trust, Eaton Road, L12 2AP, Liverpool, UK. michael.beresford@ric.nhs.uk

Articles by these authors

Mitochondrial DNA mutations in human disease. Nat Rev Genet (2005) 8.51

What causes mitochondrial DNA deletions in human cells? Nat Genet (2008) 2.70

Mitochondrial DNA and disease. J Pathol (2011) 1.81

Increased mitochondrial content in remyelinated axons: implications for multiple sclerosis. Brain (2011) 1.63

Mitochondrial donation--how many women could benefit? N Engl J Med (2015) 1.61

Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis. Ann Neurol (2010) 1.60

ETFDH mutations as a major cause of riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency. Brain (2007) 1.55

Quantification of mitochondrial DNA mutation load. Aging Cell (2009) 1.29

A national registry for juvenile dermatomyositis and other paediatric idiopathic inflammatory myopathies: 10 years' experience; the Juvenile Dermatomyositis National (UK and Ireland) Cohort Biomarker Study and Repository for Idiopathic Inflammatory Myopathies. Rheumatology (Oxford) (2010) 1.29

The UK MRC Mitochondrial Disease Patient Cohort Study: clinical phenotypes associated with the m.3243A>G mutation--implications for diagnosis and management. J Neurol Neurosurg Psychiatry (2013) 1.23

The phenotypic spectrum of neutral lipid storage myopathy due to mutations in the PNPLA2 gene. J Neurol (2011) 1.21

Duration of etanercept treatment and reasons for discontinuation in a cohort of juvenile idiopathic arthritis patients. Rheumatology (Oxford) (2010) 1.13

Pathogenic mitochondrial tRNA mutations--which mutations are inherited and why? Hum Mutat (2009) 1.11

Mitochondrial DNA mutations and ageing. Biochim Biophys Acta (2009) 1.08

Sensory neuronopathy in patients harbouring recessive polymerase γ mutations. Brain (2011) 1.03

Disease progression in patients with single, large-scale mitochondrial DNA deletions. Brain (2013) 1.02

What is influencing the phenotype of the common homozygous polymerase-γ mutation p.Ala467Thr? Brain (2012) 1.01

Comparison of mitochondrial mutation spectra in ageing human colonic epithelium and disease: absence of evidence for purifying selection in somatic mitochondrial DNA point mutations. PLoS Genet (2012) 1.01

Validity of a three-variable Juvenile Arthritis Disease Activity Score in children with new-onset juvenile idiopathic arthritis. Ann Rheum Dis (2012) 1.01

Age related mitochondrial degenerative disorders in humans. Biotechnol J (2008) 1.01

Variation in the calpain-10 gene affects blood glucose levels in the British population. Diabetes (2002) 0.96

Defects in multiple complexes of the respiratory chain are present in ageing human colonic crypts. Exp Gerontol (2010) 0.94

Age-associated mitochondrial DNA mutations lead to small but significant changes in cell proliferation and apoptosis in human colonic crypts. Aging Cell (2009) 0.92

Mitochondrial fatty acid beta-oxidation in the retinal pigment epithelium. Pediatr Res (2002) 0.90

Cytochrome c oxidase-intermediate fibres: importance in understanding the pathogenesis and treatment of mitochondrial myopathy. Neuromuscul Disord (2012) 0.89

Linking the metabolic state and mitochondrial DNA in chronic disease, health, and aging. Diabetes (2013) 0.89

Mitochondrial DNA mutations affect calcium handling in differentiated neurons. Brain (2010) 0.88

Mitochondrial and inflammatory changes in sporadic inclusion body myositis. Neuropathol Appl Neurobiol (2015) 0.88

Mitochondrial DNA deletions cause the biochemical defect observed in Alzheimer's disease. Neurobiol Aging (2011) 0.87

The low abundance of clonally expanded mitochondrial DNA point mutations in aged substantia nigra neurons. Aging Cell (2009) 0.87

Associations between high density lipoprotein mean particle size and serum paraoxonase-1 activity. J Res Med Sci (2012) 0.87

Mitochondrial DNA deletions in muscle satellite cells: implications for therapies. Hum Mol Genet (2013) 0.86

Relationship between mitochondria and α-synuclein: a study of single substantia nigra neurons. Arch Neurol (2012) 0.85

No excess of mitochondrial DNA deletions within muscle in progressive multiple sclerosis. Mult Scler (2013) 0.85

A randomized comparative trial of generalized vs targeted physiotherapy in the management of childhood hypermobility. Rheumatology (Oxford) (2009) 0.84

Microangiopathy in the cerebellum of patients with mitochondrial DNA disease. Brain (2012) 0.83

Clonally expanded mitochondrial DNA deletions within the choroid plexus in multiple sclerosis. Acta Neuropathol (2012) 0.83

HLA-DPB1 associations differ between DRB1*03 positive anti-Jo-1 and anti-PM-Scl antibody positive idiopathic inflammatory myopathy. Rheumatology (Oxford) (2009) 0.82

Mitochondrial mutations: newly discovered players in neuronal degeneration. Neuroscientist (2011) 0.82

The association between low socioeconomic status with high physical limitations and low illness self-perception in patients with juvenile idiopathic arthritis: results from the Childhood Arthritis Prospective Study. Arthritis Care Res (Hoboken) (2015) 0.82

Shape analysis of 123I-N-omega-fluoropropyl-2-beta-carbomethoxy-3beta-(4-iodophenyl) nortropane single-photon emission computed tomography images in the assessment of patients with parkinsonian syndromes. Nucl Med Commun (2009) 0.81

Reduced plasma adiponectin levels relative to oxidized low density lipoprotein and nitric oxide in coronary artery disease patients. Clinics (Sao Paulo) (2011) 0.81

Treatment outcome for adolescent obsessive-compulsive disorder in a specialized hospital setting. J Psychiatr Pract (2008) 0.81

Loss of myelin-associated glycoprotein in kearns-sayre syndrome. Arch Neurol (2012) 0.81

Analysis of mitochondrial fatty acid oxidation intermediates by tandem mass spectrometry from intact mitochondria prepared from homogenates of cultured fibroblasts, skeletal muscle cells, and fresh muscle. Pediatr Res (2002) 0.81

The associations between high-density lipoprotein mean particle size and its fatty acid composition. Biomark Med (2013) 0.80

Mitochondrial changes within axons in multiple sclerosis: an update. Curr Opin Neurol (2012) 0.80

Tufting enteropathy and skeletal dysplasia: is there a link? Eur J Pediatr (2006) 0.79

Mitochondrial DNA and genetic disease. Essays Biochem (2010) 0.78

Serum paraoxonase 1 activity is associated with fatty acid composition of high density lipoprotein. Dis Markers (2013) 0.78

Adolescent development and SLE. Best Pract Res Clin Rheumatol (2006) 0.78

Elevated plasma platelet-activating factor acetylhydrolase activity and its relationship to the presence of coronary artery disease. J Res Med Sci (2011) 0.78

Increased membrane lipid peroxidation and decreased Na+/K+-ATPase activity in erythrocytes of patients with stable coronary artery disease. Coron Artery Dis (2015) 0.77

The mitochondrial brain: From mitochondrial genome to neurodegeneration. Biochim Biophys Acta (2009) 0.76

Foot orthoses in children with juvenile idiopathic arthritis: a randomised controlled trial. Arch Dis Child (2014) 0.75

"So doctor, what exactly is wrong with my muscles? Glutaric aciduria type II presenting in a teenager". Neuromuscul Disord (2006) 0.75

Molecular dynamics simulation of chemokine receptors in lipid bilayer: a case study on C-C chemokine receptor type 2. Chem Biol Drug Des (2013) 0.75

Access to care for children and young people diagnosed with localized scleroderma or juvenile SSc in the UK. Rheumatology (Oxford) (2012) 0.75

A splice junction mutation in muscle carnitine palmitoyltransferase II deficiency. Mol Genet Metab (2003) 0.75

Management of patients with dental disease and mitochondrial disorders. Dent Update (2012) 0.75

Elevated plasma myeloperoxidase levels in relation to circulating inflammatory markers in coronary artery disease. Biomark Med (2011) 0.75